← SynDRA
SORAPRAZAN
SynDRA canonical compound SYN0031405 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | ATP4A | ATP4B |
|---|
| Mechanism of action | proton pump inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- proton pump inhibitor
- Modulator
Cross-references
Synonyms
- BY-359
- 2,3-Dimethyl-7(R)-(2-methoxyethoxy)-9(R)-phenyl-7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridin-8(R)-ol
- BYK61359
- 5XB3671655
- BYK 61359
- soraprazanum
- RefChem:184386
- Soraprazan [INN]
- Remofuscin
- SORAPRAZAN [WHO-DD]
- orb1708479
- SCHEMBL1219146
- PWILYDZRJORZDR-MISYRCLQSA-N
- UNII-5XB3671655
- MFCD21607984
- AKOS030604619
- CS-7621
- FS59620
- MS-25886
- HY-100414
- NS00124535
- G14143
- T12977
- سورابرازان
Look up SORAPRAZAN in the interactive SynDRA portal →